These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2149412)

  • 1. DNA nuclear content of apocrine cells in fibrocystic mastopathy and breast cancer.
    Vasiu R; Olinici CD
    Morphol Embryol (Bucur); 1990; 36(1):43-7. PubMed ID: 2149412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytophotometric measurements of nuclear DNA content values in human breast lesions.
    Enchev VG; Dobreva PV
    Arch Geschwulstforsch; 1987; 57(1):31-7. PubMed ID: 3566463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of cellular DNA in the study of the relations between fibrocystic disease of the breast and breast cancer].
    Lazzari G; Lamarca S
    Arch Sci Med (Torino); 1977; 134(2):137-44. PubMed ID: 869700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA content examination for atypical hyperplasia of adenosis and carcinoma of the breast].
    Jiang J
    Zhonghua Wai Ke Za Zhi; 1992 Nov; 29(12):781-3, 800. PubMed ID: 1618046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image cytometry in nonproliferative fibrocystic breast changes. Ploidy evaluation and epidemiologic study.
    Azúa-Romeo J; de Azúa-Blanco J; Romeo P
    Anal Quant Cytol Histol; 2001 Apr; 23(2):129-34. PubMed ID: 11332079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
    Selim AG; El-Ayat G; Wells CA
    Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cytospectrophotometric study of the DNA content in benign and malignant processes in the breast].
    Borodaĭ NV
    Tsitol Genet; 1999; 33(3):27-33. PubMed ID: 10474860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
    Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
    Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
    Shim HS; Jung WH; Kim H; Park K; Cho NH
    APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases.
    Moriya T; Sakamoto K; Sasano H; Kawanaka M; Sonoo H; Manabe T; Ito J
    Mod Pathol; 2000 Jan; 13(1):13-8. PubMed ID: 10658905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytospectrophotometric study of DNA content in dysplasia and breast cancer].
    Zolotarevskiĭ VB; Popov MS
    Arkh Patol; 1977 Jan; 39(1):25-31. PubMed ID: 190981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
    Selim AG; Ryan A; El-Ayat GA; Wells CA
    Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feulgen DNA cytophotometry in histologic sections of mammary neoplasms.
    Berryman I; Sterrett GF; Papadimitriou JM
    Anal Quant Cytol; 1984 Mar; 6(1):19-23. PubMed ID: 6732070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of laser flow cytometry in the study of fibrocystic mastopathy and breast cancer].
    Bogatyrev VN; Kupin VI; Polevaia EB
    Lab Delo; 1983; (9):16-8. PubMed ID: 6195424
    [No Abstract]   [Full Text] [Related]  

  • 20. Karyometric and DNA content analyses of cancer cells in stage III breast cancer with reference to prognosis.
    Tamura G; Masuda T; Satoh T; Satodate R; Ishida M; Saitoh K
    Jpn J Clin Oncol; 1990 Mar; 20(1):78-82. PubMed ID: 2157083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.